Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study.

by admin | Apr 19, 2024 | Article

Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study Study Title:Phase 2 ALXN1210-NEPH-202 Study (clinicaltrials.gov NCT04564339) Study Sponsor:Alexion, Astra Zeneca Rare Disease Purpose of Study:The purpose of...

COVID-19 VACCINE ROLLOUT

by admin | Apr 19, 2024 | Article

As provincial governments begin their rollout plans for the COVID-19 vaccine we encourage you to speak with your healthcare team or...

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

by admin | Apr 19, 2024 | Article

https://www.lupuscanada.org/wp-content/uploads/AZD1222_PhIII-US-HLR_RNS.pdf

Dr. Samir Gupta explains how the four COVID-19 vaccines now approved in Canada work and why efficacy rates aren’t the most important number to look at.

by admin | Apr 19, 2024 | Article

https://www.cbc.ca/player/play/1880969283645

Six Bio-Ethicists on Ontario Government’s “Bioethics Table” Confirm Ongoing Concerns Raised by Disability Organizations regarding the Discriminatory and Secret Plans for the Triaging of Critical Care

by admin | Apr 19, 2024 | Article

https://archdisabilitylaw.ca/news-release-for-immediate-release-six-bio-ethicists-on-ontario-governments-bioethics-table-confirm-ongoing-concerns-raised-by-disability-organizations-regarding-the-dis

LUPUS AND COVID-19 VACCINATION WAIT TIMES

by admin | Apr 19, 2024 | Article

May 6, 2021 Source:Christine A. Peschken MD MSc FRCPCHead, Section of RheumatologyActing Head, Section of Allergy and ImmunologyProfessor of Medicine and Community Health SciencesMax Rady College of Medicine, Rady Faculty of Health SciencesUniversity of ManitobaChair,...